Janux Therapeutics, Inc. (JANX)

NASDAQ: JANX · IEX Real-Time Price · USD
13.80
-0.04 (-0.29%)
Aug 8, 2022 4:00 PM EDT - Market closed

Cash Flow Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 202120202019
Net Income
-32.67-6.78-4
Depreciation & Amortization
0.110.010.01
Share-Based Compensation
6.910.070.01
Other Operating Activities
8.672.330.16
Operating Cash Flow
-16.98-4.37-3.83
Capital Expenditures
-1.4800
Change in Investments
-339.4800
Investing Cash Flow
-340.9600
Share Issuance / Repurchase
205.980.070
Debt Issued / Paid
02.54
Other Financing Activities
180.558.950
Financing Cash Flow
386.5211.524
Net Cash Flow
28.597.160.17
Free Cash Flow
-18.46-4.37-3.83
Free Cash Flow Margin
-507.51%--
Free Cash Flow Per Share
-0.78-4.77-5.72
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).